Keyphrases
Virus Vaccine
83%
Herpes Simplex Virus 2 (HSV-2)
83%
Mucosal Immune Response
83%
Herpes Simplex Virus
83%
Herpes Simplex Virus Type 1 (HSV-1)
71%
Skin Scarification
28%
Virus
23%
Immune Serum
23%
Complementing Cells
23%
Dorsal Root Ganglion
23%
Immune Response
23%
Genital Diseases
14%
Challenge Virus
14%
Prime-boost
14%
Fc Neonatal Receptor
14%
Subcutaneous Immunization
14%
Serum Neutralizing Antibodies
11%
Latency
11%
2-simplex
11%
Novel Vaccines
11%
Antibody Repertoire
11%
No Evidence of Disease
11%
Knock-in Mouse Model
11%
Vaccine Strain
11%
Passive Transfer
11%
CD8+ T Cell Response
11%
CD4+ T Cell Response
11%
Infant Morbidity
11%
Receptor Knockout
11%
Immune Protection
11%
Immunogenicity
11%
Male Mice
11%
Vaccine Strategy
11%
Viral Reservoir
11%
SCID Mice
11%
Vaccine Response
11%
Cotton Rat
11%
Humoral Immunity
11%
Cytoxicity
11%
Wild Type Virus
11%
Clinical Trials
11%
Herpes Simplex Virus Infection
11%
Mucosal Sites
11%
World Population
11%
Cellular Immunity
11%
Female Mice
11%
Germinal Center
11%
Protective Immune Response
11%
Perinatal Transmission
11%
Glycoprotein D
11%
High Titer
11%
Subunit Vaccine
11%
Plaque
11%
Global Health Issue
11%
Glycoprotein
11%
Complete Protection
11%
Biological Basis
11%
Immunogen
11%
Cell-mediated
11%
Vero Cells
11%
Nave
11%
Disease Transmission
11%
Neutralizing Antibodies
11%
Immunology and Microbiology
Herpes Simplex Vaccine
100%
Herpes Simplex Virus 2
83%
Monospecific Antibody
83%
Mouse
71%
Human Alphaherpesvirus 1
71%
Vaccine Efficacy
47%
Immune Response
35%
Neutralizing Antibody
23%
Serotype
23%
Dorsal Root
23%
Human Immunodeficiency Virus
23%
Glycoprotein
23%
Scar Formation
23%
Ganglion
23%
Antiserum
23%
Wild Type
23%
Neonatal Fc Receptor
14%
Cotton Rat
14%
Adoptive Immunity
11%
Virus Vaccine
11%
Cytotoxic T-Cell
11%
Virus Type
11%
Viral Disease
11%
Antigen
11%
Herpes Simplex Virus
11%
Titer
11%
Humoral Immunity
11%
Germinal Center
11%
Subunit Vaccine
11%
Knockout Mouse
11%
SCID Mouse
11%
T-Helper Cell
11%
Antibody Response
11%
Immunogenicity
11%